IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector

被引:418
作者
Mizuguchi, H [1 ]
Xu, ZL [1 ]
Ishii-Watabe, A [1 ]
Uchida, E [1 ]
Hayakawa, T [1 ]
机构
[1] Natl Inst Hlth Sci, Div Biol Chem & Biol, Setagaya Ku, Tokyo 1588501, Japan
关键词
IRES; EMCV; bicistronic vector; gene therapy;
D O I
10.1006/mthe.2000.0050
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The internal ribosome entry site (IRES) has been widely used to coexpress heterologous gene products by a message from a single promoter. However, little is known about the efficiency of IRES-dependent second gene expression in comparison with that of first gene expression. This study was undertaken to characterize the relative expression of IRES-dependent second gene in a bicistronic vector, which was derived from the 5' untranslated regions of the encephalomyocarditis virus (EMCV). IRES-dependent second gene expression was compared with cap-dependent first gene expression in several cultured cell lines and in mouse liver in vivo. The expression of the IRES-dependent second gene ranged from 6 to 100% (in most cases between 20 and 50%) that of the first gene. Second gene expression in a plasmid without the IRES was 0.1-0.8% (with some exceptions) that of the first gene. These findings have important implications for the use of IRES, i.e., care should be taken regarding the decreased capacity of IRES-dependent downstream gene expression as well as in determining which gene should be positioned as the first or second gene in a bicistronic vector.
引用
收藏
页码:376 / 382
页数:7
相关论文
共 34 条
[31]   Production and characterization of a bicistronic Moloney-based retroviral vector expressing human interleukin 2 and herpes simplex virus thymidine kinase for gene therapy of cancer [J].
Pizzato, M ;
Franchin, E ;
Calvi, P ;
Boschetto, R ;
Colombo, M ;
Ferrini, S ;
Palu, G .
GENE THERAPY, 1998, 5 (07) :1003-1007
[32]  
Rees S, 1996, BIOTECHNIQUES, V20, P108
[33]   Multicomponent gene therapy vaccines for lung cancer: effective eradication of established murine tumors in vivo with interleukin-7/herpes simplex thymidine kinase-transduced autologous tumor and ex vivo activated dendritic cells [J].
Sharma, S ;
Miller, PW ;
Stolina, M ;
Zhu, L ;
Huang, M ;
Paul, RW ;
Dubinett, SM .
GENE THERAPY, 1997, 4 (12) :1361-1370
[34]   A novel dicistronic AAV vector using a short IRES segment derived from hepatitis C virus genome [J].
Urabe, M ;
Hasumi, Y ;
Ogasawara, Y ;
Matsushita, T ;
Kamoshita, N ;
Nomoto, A ;
Colosi, P ;
Kurtzman, GJ ;
Tobita, K ;
Ozawa, K .
GENE, 1997, 200 (1-2) :157-162